3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Vitamin D Deficiency
3
Prostatic Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
2
Triple Negative Breast Neoplasms
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Psoriasis
1
Osteoporosis Secondary
1
Osteoarthritis
1
Obesity
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Primary Cutaneous Anaplastic Large Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Immunoblastic Lymphadenopathy
1
Fractures, Stress
1
Enteropathy-Associated T-Cell Lymphoma
1
Colorectal Adenocarcinoma
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Intraductal, Noninfiltrating
1
Bone Metabolism Biomarkers
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
13
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Bendamustine Hydrochloride
10
Magnetic Resonance Spectroscopy
9
Whole-Body Irradiation
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
Specimen Handling
7
CT-P10
7
Mycophenolic Acid
6
Biopsy
6
Doxorubicin
5
tafasitamab
4
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Melphalan
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Cholecalciferol
×
1 year
×
Clear all
No trials found.